Skip to Content

MYLAN 217 250 (Tolazamide 250 mg)

Pill with imprint MYLAN 217 250 is White, Round and has been identified as Tolazamide 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 217 250

Tolazamide 250 mg MYLAN 217 250
Tolazamide 250 mg MYLAN 217 250 Front
Tolazamide 250 mg MYLAN 217 250 Back
Tolazamide 250 mg MYLAN 217 250

Tolazamide

Imprint
MYLAN 217 250
Strength
250 mg
Color
White
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-0217 Mylan Pharmaceuticals Inc.
68084-0556 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.